Production (Stage)
Ekso Bionics Holdings, Inc.
EKSO
$0.2798
$0.00120.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.69% | -6.19% | 38.42% | 42.88% | 21.87% |
| Total Depreciation and Amortization | -6.90% | -7.87% | -4.01% | -7.24% | -1.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -139.69% | 466.90% | -115.86% | -16.47% | 55.66% |
| Change in Net Operating Assets | 178.78% | -103.06% | 64.55% | -376.86% | -68.20% |
| Cash from Operations | 43.31% | 9.53% | 32.09% | 8.03% | 17.75% |
| Capital Expenditure | -25.00% | 51.16% | 52.94% | 100.00% | 80.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -25.00% | 51.16% | 52.94% | 100.00% | 80.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.32% | -- | -- | -- |
| Issuance of Common Stock | -3.22% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.50% | -190.23% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 131.82% | -55.00% | -- | 275.00% | -375.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 869.57% | -38.49% | 171.42% | 1.89% | 103.79% |